Verseon Corporation is a pharmaceutical company. The Company's platform models interactions between a protein and a drug molecule with precision sufficient for designing drug candidates. The Company operates through the pharmaceutical research segment. The Company uses its drug discovery technology to develop a portfolio of programs targeting disease areas consisting of anti-coagulation, diabetic macular edema (DMA) and oncology. The Company's platform generates a range of drug-like, synthesizable compounds, which are then computationally tested against a disease-causing protein to identify the binders, the drug candidates that could potentially treat the disease. These computationally designed candidates are synthesized and sent through a series of disease specific in vitro and in vivo tests to identify the candidates for clinical testing in humans.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Biotechnology & Medical Research - NEC
- Sub-Industry: N/A
- Symbol: LON:VSN
- CUSIP: N/A
- Web: www.verseon.com/
- Market Cap: £221.82 million
- Outstanding Shares: 151,414,000
- 50 Day Moving Avg: GBX 146.85
- 200 Day Moving Avg: GBX 154.33
- 52 Week Range: GBX 140 - GBX 166.90
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: N/A
- Price / Sales: N/A
- Book Value: GBX 0.40 per share
- Price / Book: 3.66
- EBIDTA: ($17,040,000.00)
- Return on Equity: -3.57%
- Return on Assets: -2.33%
- Average Volume: 54,648 shs.
Frequently Asked Questions for Verseon Corp (LON:VSN)
What is Verseon Corp's stock symbol?
Verseon Corp trades on the London Stock Exchange (LON) under the ticker symbol "VSN."
When will Verseon Corp make its next earnings announcement?
Who are some of Verseon Corp's key competitors?
Some companies that are related to Verseon Corp include Novavax (NVAX), Adamas Pharmaceuticals (ADMS), Abeona Therapeutics (ABEO), PDL BioPharma (PDLI), Celyad SA (CYAD), Concert Pharmaceuticals (CNCE), Puretech Health PLC (PRTC), Celldex Therapeutics (CLDX), Curis (CRIS), Nabriva Therapeutics AG (NBRV), Idera Pharmaceuticals (IDRA), Advaxis (ADXS), Codexis (CDXS), Voyager Therapeutics (VYGR), Corvus Pharmaceuticals (CRVS), Organovo Holdings (ONVO), Horizon Discovery Group PLC (HZD) and Zynerba Pharmaceuticals (ZYNE).
Who are Verseon Corp's key executives?
Verseon Corp's management team includes the folowing people:
- Adityo Prakash, Chief Executive Officer, Founder, Executive Director
- Eniko Fodor, Founder, Chief Financial Officer, Chief Operating Officer, Executive Director
- David Kita, Founder, Vice President - Research & Development
- Anirban Datta, Director - Discovery Biology
- Kevin Short, Director - Discovery Programs
- David Williams, Director - R&D
- Thomas A Hecht, Non-Executive Chairman of the Board
- Alastair Andrew Bertram Cade, Non-Executive Director
- Grover T. Wickersham, Non-Executive Director
How do I buy Verseon Corp stock?
Shares of Verseon Corp and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Verseon Corp's stock price today?
MarketBeat Community Rating for Verseon Corp (LON VSN)MarketBeat's community ratings are surveys of what our community members think about Verseon Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Verseon Corp stock can currently be purchased for approximately GBX 146.50.
Consensus Ratings for Verseon Corp (LON:VSN) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Verseon Corp (LON:VSN)
(Data available from 7/25/2015 forward)
|7/4/2017||Cenkos Securities Ltd||Reiterated Rating||Buy|
Earnings History for Verseon Corp (LON:VSN)Earnings History by Quarter for Verseon Corp (LON VSN)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for Verseon Corp (LON:VSN)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Verseon Corp (LON:VSN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Verseon Corp (LON:VSN)Insider Trades by Quarter for Verseon Corp (LON:VSN)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
Headline Trends for Verseon Corp (LON:VSN)
Latest Headlines for Verseon Corp (LON:VSN)
Verseon Corp (VSN) Chart for Tuesday, July, 25, 2017